Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TVAX-008 in Treated Chronic Hepatitis B
NCT07190742Phase 2Active, not recruiting
- Sponsor
- Grand Theravac Life Science (Nanjing) Co., Ltd.
- Start
- Jun 2023
- Primary completion
- Oct 2024
- Modality
- Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of TVAX-008 in Chronic Hepatitis B (CHB), sponsored by Grand Theravac Life Science (Nanjing) Co., Ltd.. Started Jun 2023; status: active, not recruiting.
02
Drugs
TVAX-008
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT07190742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07190742.